Generated by Yoast SEO v25.7, this is an llms.txt file, meant for consumption by LLMs.

The XML sitemap of this website can by found by following [this link](https://novalgen.com/sitemap_index.xml).

# Novalgen: Breakthrough multi\-specific antibody therapies

> NovalGen is an innovative immunotherapy company focused on next\-generation multi\-specific antibody approaches

## Pages
- [Careers](https://novalgen.com/careers/)
- [Pipeline](https://novalgen.com/pipeline/)
- [AutoRegulation platform](https://novalgen.com/our-technologies/autoregulation-platform/)
- [NovalGen](https://novalgen.com/)
- [Patients \& families](https://novalgen.com/patients-families/)

## Team
- [Alexander Boches](https://novalgen.com/about-us/our-team/alexander-boches/)
- [Nitin Shah](https://novalgen.com/about-us/our-team/nitin-shah-2/)
- [Bharat Thakrar](https://novalgen.com/about-us/our-team/bharat-thakrar/)
- [Professor Amit Nathwani](https://novalgen.com/about-us/our-team/professor-amit-nathwani/)
- [Dr Kieran O’Donovan](https://novalgen.com/about-us/our-team/dr-kieran-odonovan/)

## News publications
- [NovalGen Appoints Dr Laurent Fischer as Chair of the Board](https://novalgen.com/news-publications/news/novalgen-appoints-dr-laurent-fischer-as-chair-of-the-board/)
- [Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T\-cell engager NVG\-222](https://novalgen.com/news-publications/news/cancer-research-uk-and-novalgen-dose-the-first-patient-in-the-phase-1-trial-of-t-cell-engager-nvg-222/)
- [NovalGen to Begin World’s First Clinical Trial for a Self\-Regulating Immunotherapy](https://novalgen.com/news-publications/news/novalgen-to-begin-worlds-first-clinical-trial-for-a-self-regulating-immunotherapy/)
- [Drug Developer Mabion, Releases First Batch of Novalgen’s Next\-Generation T\-CELL Engager, NVG\-222 for First In\-Human Clinical Trials\.](https://novalgen.com/news-publications/news/drug-developer-mabion-releases-first-batch-of-novalgens-next-generation-t-cell-engager-nvg-222-for-first-in-human-clinical-trials/)
- [NovalGen to collaborate with CRUK to progress NVG\-222 into a Phase I clinical study](https://novalgen.com/news-publications/news/novalgen-to-collaborate-with-cruk-to-progress-nvg-222-into-a-phase-i-clinical-study/)